Cabot Q3 EPS Beats by a Penny, Revenue Up 6%; CEO Transition Set
CBT sits 54% above its 52-week low of $58.33.
Summary
Cabot's fiscal Q3 adjusted EPS of $1.67 edged past the $1.66 consensus, with revenue rising 6% to $982 million. Performance Chemicals drove the beat with 19% EBIT growth on battery materials and fumed metal oxides, while Reinforcement Materials EBIT fell 24% on lower margins from 2026 customer agreements. The company tightened its FY26 adjusted EPS guidance to $6.15–$6.45 from $6.00–$6.50, and reaffirmed ~$40 million EBITDA for battery materials. CEO Sean Keohane will retire September 30, with CFO Erica McLaughlin taking over October 1 — a transition previously disclosed but now confirmed alongside results. The stock trades at 13x forward earnings, with a median analyst target of $97.
At the time of this announcement, CBT was trading at $89.58 on NYSE in the Manufacturing sector, with a market capitalization of approximately $4.6B. The 52-week trading range was $58.33 to $94.53. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.